Kabushiki Kaisha Dnaform
USPTO PatentsView assignee record - 8 granted patents across 7 technology areas, recorded in grant years 2016–2022. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: C12Q (Measuring OR Testing Processes Involving Enzymes, Nucleic Acids OR Microorganisms ; Compositions OR Test Papers THEREFOR; Processes OF Preparing Such COMPOSITIONS; Condition-responsive Control IN Micr).
The verdict
According to USPTO PatentsView, Kabushiki ranks #32,209 of 49,997 tracked US assignees by granted-patent volume, with 8 patents across 7 technology areas.
- #32,209
- of 49,997 US assignees by volume
- 33rd percentile
- by Innovation Score (30.1/100)
- 18.3
- avg claims per patent
- -67%
- grant velocity, last 5 yrs
USPTO PatentsView assignee plate
Corpus R32209 · Foreign Corporation #32,209 · 8 grants
GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-RICH · TYPE-FRNCORP · VEL-DROP · BOOK-FULL
- GRANTS-MICRO 8 grants
- MID-PACK #32,209/49,997
- PHOTO-FINISH K-
- CPC-NARROW C12Q · 7 areas
- INNOV-THIN 30.1/100
- CLAIMS-RICH 18.3 claims/avg
- TYPE-FRNCORP Foreign Corp
- VEL-DROP -67% vel
- BOOK-FULL 10/10 fields
Nearest grant-volume peer: K-Technologies, Inc. (±0 grants)
Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.
How Kabushiki’s 30.1 Innovation Score adds up
The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.
Innovation-score neighbourhood around Kabushiki
Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.
- Qualcomm Incorporated · highest
Qualcomm Incorporated · highest
85 score
- Dnaform · this assignee 30
Dnaform · this assignee
30 score
- 3D Lighting… · lowest 7
3D Lighting… · lowest
7 score
What this shows Kabushiki's Innovation Score is 30.1/100 (33rd percentile of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.
Does more volume mean deeper claims for Kabushiki?
Each dot is one of Kabushiki’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Kabushiki’s own 18.3 claims/patent is ABOVE the 10.1 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.
Where Kabushiki's grants concentrate
Kabushiki Kaisha Dnaform is a focused PatentsView assignee: 7 CPC subclasses with 100% of grants classified under C12Q (Measuring OR Testing Processes Involving Enzymes, Nucleic Acids OR Microorganisms ; Compositions OR Test Papers THEREFOR; Processes OF Preparing Such COMPOSITIONS; Condition-responsive Control IN Micr). Peak complete grant year is 2018 (2 grants) versus a trough of 1 in 2016. By volume, Kabushiki sits between K-technology USA, Inc. and Kairish Innotech Private Ltd..
Kabushiki's three-year grant acceleration
Kabushiki Kaisha Dnaform shows 1 grants in 2022–2024 against only 3 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.
Who files at Kabushiki's volume?
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
- K-technology USA
K-technology USA, Inc.
8 patents
- K-
K-Technologies, Inc.
8 patents
- K L Kaschier- UND…
K.L. Kaschier- UND Laminier GMBH
8 patents
- Kaarya
Kaarya LLC
8 patents
- Kabushiki Kaisya…
Kabushiki Kaisya Leben Hanbai
8 patents
- Kaia Health Softw…
Kaia Health Software GMBH
8 patents
- Kaijet Technology…
Kaijet Technology International Corporation
8 patents
- Kairish Innotech…
Kairish Innotech Private Ltd.
8 patents
- Dnaform ◀
Kabushiki Kaisha Dnaform
8 patents
What this shows Kabushiki holds 8 patents at rank #32,197, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
Companies ranked near Kabushiki
By rank, the assignees closest to #32,197 in granted patent volume.
- K-technology USA, Inc. #32,193 · 8 patents
- K-Technologies, Inc. #32,194 · 8 patents
- K.L. Kaschier- UND Laminier GMBH #32,195 · 8 patents
- Kaarya LLC #32,196 · 8 patents
- Kabushiki Kaisya Leben Hanbai #32,198 · 8 patents
- Kaia Health Software GMBH #32,199 · 8 patents
- Kaijet Technology International Corporation #32,200 · 8 patents
- Kairish Innotech Private Ltd. #32,201 · 8 patents
Leaders in C12Q (Measuring OR Testing Processes Involving Enzymes)
Other assignees with the most granted patents in Kabushiki's primary technology class.
- The Regents of the University of California 581 in class
- Life Technologies Corporation 546 in class
- Illumina, Inc. 445 in class
- President and Fellows of Harvard College 387 in class
- Immatics Biotechnologies GmbH 286 in class
- 10x Genomics, Inc. 282 in class
- The Board of Trustees of the Leland Stanford Junior University 266 in class
- Pacific Biosciences OF California, Inc. 259 in class
Kabushiki's Innovation Score vs. every tracked assignee
Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)
30 33rd percentile higher than 33% of 49,997 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Grants by year
Teal-shaded recent years (2020–present) versus the 2016–2019 baseline. Full figures in the table below.
View data table
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2016 | 1 | 12.5% |
| 2017 | 1 | 12.5% |
| 2018 | 2 | 25.0% |
| 2019 | 2 | 25.0% |
| 2020 | 1 | 12.5% |
| 2022 | 1 | 12.5% |
Which technologies does Kabushiki Kaisha Dnaform patent most?
Top 7 of 7 technology areas
Data Source
USPTO PatentsView, US granted patents 2015–2025
What to do with this data
Kabushiki Kaisha Dnaform's patent record in context - here's where to go next.
- Kabushiki Kaisha Dnaform's lead technology class is C12Q (Measuring OR Testing Processes Involving Enzymes, Nucleic Acids OR Microorganisms ; Compositions OR Test Papers THEREFOR; Processes OF Preparing Such COMPOSITIONS; Condition-responsive Control IN Micr), 100% of its portfolio - see every assignee active in that class. Explore C12Q
- Ranked #32,209 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
- Compare Kabushiki Kaisha Dnaform against K-technology USA, Inc., an assignee filing at a similar volume. Compare portfolios
- Innovation Score of 30.1/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated
Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.